Abstract
DESPITE considerable evidence that immune mechanisms are involved in the pathogenesis of diffuse renal vascular diseases of various types, the results of immunosuppressive therapy in such patients have been variable though generally disappointing, especially in the adult age group.2 3 4 5 6 7 8 9 The present report describes a program of combined corticosteroid and azathioprine therapy of 32 patients, predominantly in the pediatric age range, with life-threatening forms of these diseases. The results of the first two years of the study suggest that in many of these younger patients this combined therapy brings about significant improvement.PatientsThirty-two patients with renal disease were treated with . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
